Many startups are giving patients options to receive care that cuts out insurers. This includes online pharmacies, direct primary care platforms and lending companies. These startups are creating change among payers, some experts say.
Join us for an introduction to the OBGYN-specific EHR designed to adapt to the way OBGYNs specifically work. ModMed Presenters: Dr. Sherling, Chief Medical/Strategy Officer and OBGYN's: Dr. Ecklund, Medical Director & Dr. Spier, Team Lead
Join us September 28 at Pegasus Park in Dallas to meet select Employee Benefits Startups, over 30 investors, and to be a part of the thought provoking discussions around mental health, pharmacy benefits, the cost of healthcare, and reaching consumers.
By Stephanie Baum Monday, September 19, 2022 7:30 AM
Hospitals struggle to retain switchboard and call center staff, a situation exacerbated by inflation. Here's how Parlance is leveraging its call automation tech to help address these needs and improve the caller experience.
By Stephanie Baum Monday, September 19, 2022 7:00 AM
Among the topics of discussion at the event within the HLTH conference are: making the future of food and nutrition accessible and sustainable, managing and monitoring sleep health, and destigmatizing sexual health and wellness. Register today!
To more effectively implement meaningful solutions that help ensure that access to affordable sexual and reproductive healthcare is treated as a right and not a privilege, we must identify and examine why these challenges persist.
By Danielle Jablanski Monday, September 19, 2022 12:43 AM
Much like a house of mirrors, responsibility for understanding and mitigating cyber risk in healthcare is difficult to distinguish and often depends on who you ask, especially when it comes to non-enterprise systems and devices.
By Michelle Northey Monday, September 19, 2022 12:16 AM
More flexibility and control over shift scheduling, tools to reduce admin burnout, and same-day pay all go a long way in helping to relieve the looming burnout crisis.
By Frank Vinluan Sunday, September 18, 2022 9:11 AM
The biggest biotech financing of the past week belongs to a startup developing an immunology drug that could rival blockbuster products sold by big pharmaceutical companies. Cell therapy, cancer, and rare disease also figured into this week's startup cash hauls.
No comments